Back to Search
TROY BUCHHOLZ, M.D.
M.D.
Family Medicine Physician
NPI: 1154315976IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF IOWA, RJ & L CARVER COLLEGE OF MEDICINE
Class of 2000
Research & Publications (20)
Radiation therapy for early-stage breast cancer after breast-conserving surgery.
PMID 19118305·N Engl J Med·2009
6-review
Identifying the "sentinel lymph nodes" for arm drainage as a strategy for minimizing the lymphedema risk after breast cancer therapy.
PMID 19184413·Breast Cancer Res Treat·2009
8-other
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
PMID 18258988·J Clin Oncol·2008
6-review
Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes.
PMID 18234447·Int J Radiat Oncol Biol Phys·2008
8-other
Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer.
PMID 16750325·Int J Radiat Oncol Biol Phys·2006
3-trial
The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers.
PMID 16421417·J Clin Oncol·2006
4-observational
The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.
PMID 16322301·Clin Cancer Res·2005
8-other
Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy.
PMID 15981280·Cancer·2005
8-other
Is partial breast irradiation a step forward or backward?
PMID 15809931·Semin Radiat Oncol·2005
6-review
Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy.
PMID 15275718·Int J Radiat Oncol Biol Phys·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1455 MAIN ST, SUIT 100
WINDSOR, CO 80550 - Phone
- (970) 686-3950
Quick Facts
- NPI
- 1154315976
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile